Public Disclosure

Canadian Anti-Doping Program (CADP) Rule 14.3 deals with public disclosure.

Once the CCES has completed a review described in Rules 7.2, 7.4, 7.5, 7.6, and/or 7.7, and provided all the required notices, the CCES may publicly report the identity of any athletes whose samples have resulted in Adverse Analytical Findings, or athletes or other persons who were asserted by it to have violated other anti-doping rules. Neither the CCES nor a sport organization may publicly report the identity of an athlete or other person against whom the CCES may assert an anti-doping rule violation until the assertion against the athlete or other person is formally made.

Within twenty (20) days after it has been determined on a hearing or on an appeal whether an anti-doping rule violation has occurred, or such hearing or appeal has been waived, or the assertion of an anti-doping rule violation has not been timely challenged, the CCES shall publicly report the disposition of the anti-doping matter, including:

  • The sport;
  • The anti-doping rule violation violated;
  • The name of the athlete or other person committing the violation;
  • The prohibited substance or method involved; and
  • The consequences imposed.

In any case where it is determined after a hearing or an appeal that the athlete or other person did not commit an anti-doping rule violation, the full written decision may be disclosed publicly only with the consent of the athlete or other person. In the event the consent to disclose the full written decision is not received, the written decision shall be made public but in a redacted form to entirely hide the identity of the athlete or other person involved.